Regeneron (REGN) – Mergers and Acquisitions
-
Regeneron (REGN) Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio (TSVT) Platforms and Preclinical and Clinical Programs
-
Jefferies discusses potential GLP1/obesity buyers and M&A targets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to REGN Stock Lookup